Identification of ENO1 as a prognostic biomarker and molecular target among ENOs in bladder cancer

被引:0
作者
Zhengnan Huang
Yilin Yan
Tengjiao Wang
Zeyi Wang
Jinming Cai
Xiangqian Cao
Chenkai Yang
Fang Zhang
Gang Wu
Bing Shen
机构
[1] Tongji University,Department of Urology, Tongji Hospital, School of Medicine
[2] Shanghai General Hospital,Department of Urology
[3] Shanghai Jiaotong University School of Medicine,Department of Stem Cells and Regenerative Medicine
[4] Shanghai Key Lab of Cell Engineering,Department of Urology
[5] Translational Medicine Research Center,undefined
[6] Naval Medical University,undefined
[7] Shanghai General Hospital Affiliated to Nanjing Medical University,undefined
来源
Journal of Translational Medicine | / 20卷
关键词
Bladder cancer; Enolase; Prognostic biomarker; Molecular target; Immune infiltration;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 211 条
[1]  
Kaufman DS(2009)Bladder cancer Lancet 374 239-249
[2]  
Shipley WU(2021)Cancer Statistics, 2021 CA Cancer J Clin 71 7-33
[3]  
Feldman AS(2020)Bladder cancer: a review JAMA 324 1980-1991
[4]  
Siegel RL(2020)Treatment of muscle-invasive and advanced bladder cancer in 2020 CA Cancer J Clin 70 404-423
[5]  
Miller KD(2011)Aerobic glycolysis: meeting the metabolic requirements of cell proliferation Annu Rev Cell Dev Biol 27 441-464
[6]  
Fuchs HE(2020)We need to talk about the Warburg effect Nat Metab 2 127-129
[7]  
Jemal A(2021)Current development and application of anaerobic glycolytic enzymes in urothelial cancer Int J Mol Sci 22 19-2636
[8]  
Lenis AT(2017)Non-metabolic functions of glycolytic enzymes in tumorigenesis Oncogene 36 2629-11
[9]  
Lec PM(2019)Enzyme targeting strategies for prevention and treatment of cancer: Implications for cancer therapy Semin Cancer Biol 56 1-513
[10]  
Chamie K(2005)Molecular evolution of enolase Acta Biochim Pol 52 507-7173